DE69325091D1 - Ernährungsprodukt für verletzte und chirurgische patienten - Google Patents

Ernährungsprodukt für verletzte und chirurgische patienten

Info

Publication number
DE69325091D1
DE69325091D1 DE69325091T DE69325091T DE69325091D1 DE 69325091 D1 DE69325091 D1 DE 69325091D1 DE 69325091 T DE69325091 T DE 69325091T DE 69325091 T DE69325091 T DE 69325091T DE 69325091 D1 DE69325091 D1 DE 69325091D1
Authority
DE
Germany
Prior art keywords
injured
nutritional product
surgical patients
surgical
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69325091T
Other languages
English (en)
Other versions
DE69325091T2 (de
Inventor
Mary Henningfield
John Mcewen
Robert Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69325091D1 publication Critical patent/DE69325091D1/de
Application granted granted Critical
Publication of DE69325091T2 publication Critical patent/DE69325091T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/80—Geriatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/81—Energy rations, e.g. emergency rations, survival rations
DE69325091T 1992-02-26 1993-02-08 Ernährungsprodukt für verletzte und chirurgische patienten Expired - Lifetime DE69325091T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/840,972 US5221668A (en) 1992-02-26 1992-02-26 Nutritional product for trauma and surgery patients
PCT/US1993/001100 WO1993016595A1 (en) 1992-02-26 1993-02-08 Nutritional product for trauma and surgery patients

Publications (2)

Publication Number Publication Date
DE69325091D1 true DE69325091D1 (de) 1999-07-01
DE69325091T2 DE69325091T2 (de) 1999-12-23

Family

ID=25283701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325091T Expired - Lifetime DE69325091T2 (de) 1992-02-26 1993-02-08 Ernährungsprodukt für verletzte und chirurgische patienten

Country Status (12)

Country Link
US (1) US5221668A (de)
EP (1) EP0630181B1 (de)
JP (1) JP2644086B2 (de)
AU (1) AU3614393A (de)
CA (1) CA2128078C (de)
DE (1) DE69325091T2 (de)
DK (1) DK0630181T3 (de)
GR (1) GR3030642T3 (de)
HK (1) HK1011597A1 (de)
MX (1) MX9300999A (de)
NZ (1) NZ249392A (de)
WO (1) WO1993016595A1 (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660630B2 (en) * 1990-10-01 1995-07-06 Brigham And Women's Hospital Beta-carotene and vitamin E therapy for inhibition of major vascular events
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5714161A (en) * 1993-04-22 1998-02-03 Colgate Palmolive Company Syringeable enteral diet for animals in a hypermetabolic state caused by the stress of medical and surgical illness
US5424299A (en) * 1993-04-23 1995-06-13 Monte; Woodrow C. Composition and method for rejuvenating enteral feeding tubes
US5547927A (en) * 1993-05-28 1996-08-20 Abbott Laboratories Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5514656A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
US5480872A (en) * 1993-05-28 1996-01-02 Abbott Laboratories Method of providing enternal nutritional support to persons infected with human immunodeficiency virus
US5403826A (en) * 1993-05-28 1995-04-04 Abbott Laboratories Nutritional product for persons infected with human immunodeficiency virus
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
US5891459A (en) * 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5656588A (en) * 1994-07-19 1997-08-12 Wake Forest University Wound healing formula
US5550113A (en) * 1994-07-20 1996-08-27 Mann; Morris A. Blood sugar regulating composition and methods relating thereto
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US6190704B1 (en) * 1994-09-23 2001-02-20 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
CA2222278C (en) * 1995-06-06 2008-05-13 Campbell Soup Company Mineral supplements for dietetic food
WO1996039050A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Therapeutic system for dietary health management
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
WO1996039052A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Compliance support package for increasing health management system compliance
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
US5635199A (en) * 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
US6281244B1 (en) * 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine
ES2265669T3 (es) * 1997-09-16 2007-02-16 Societe Des Produits Nestle S.A. Uso de una composicion nutritiva especifica para un organo.
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
AU3221599A (en) * 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
ID24710A (id) * 1998-05-12 2000-08-03 Nutricia Nv Komposisi nutrisi untuk perawatan luka karena tekanan
US6288116B1 (en) 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US6245379B1 (en) 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
EP1023843B1 (de) * 1999-01-29 2005-06-22 Sportmedizin Team Vertriebs GmbH Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
WO2001011990A1 (en) * 1999-04-29 2001-02-22 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
CA2376375C (en) * 1999-06-05 2011-07-12 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
US6838431B2 (en) * 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
CA2348067A1 (en) * 1999-07-27 2001-03-15 Robert Portman Composition for extending post meal satiety
EP1090636A1 (de) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. Diät mit hohem Lipidgehalt
US6214373B1 (en) * 1999-10-07 2001-04-10 Snowden-Sutton Associates, Inc. Nutritional composition for treating inflammatory bowel diseases
JP2003514855A (ja) * 1999-10-13 2003-04-22 チャコン，マルコ，エー． カロリー制限の効果を模倣した治療的介入
SE523432C2 (sv) * 2000-01-12 2004-04-20 Mjoelkkannan Foervaltning Ab C Näringsdryck
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6989164B2 (en) * 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
KR20010070584A (ko) * 2001-05-25 2001-07-27 한승관 일산화질소와 리놀레산을 이용한 신기능 물질의 제조방법및 그 이용방법
US6605310B2 (en) * 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
KR20050069975A (ko) * 2002-07-29 2005-07-05 하와이 바이오테크, 인코포레이티드 질병의 억제 및 완화를 위한 카로티노이드 구조 유사체
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US8100879B2 (en) 2002-11-18 2012-01-24 Nestec S.A. Connector device for enteral administration set
BRPI0408490A (pt) * 2003-03-18 2006-04-04 Novartis Ag composições que compreendem ácidos graxos e aminoácidos
EP1475434A1 (de) * 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
JP2007526316A (ja) * 2004-03-01 2007-09-13 ルーメン セラピューティックス リミテッド ライアビリティ カンパニー 疾患を処置するための組成物および方法
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20050271726A1 (en) * 2004-06-02 2005-12-08 Albert Crum Immune enhancing compositions and methods of use thereof
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20070281961A1 (en) * 2006-06-05 2007-12-06 Brite Age Modified Compositions And Methods For Enhancing Brain Function
US8883814B2 (en) 2006-06-05 2014-11-11 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US10105406B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
US8071610B2 (en) * 2006-06-05 2011-12-06 Josh Reynolds Compositions and methods for enhancing brain function
US9308232B2 (en) 2006-06-05 2016-04-12 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US10105405B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
ES2425991T3 (es) * 2006-08-23 2013-10-18 Kellogg Company Método destinado a eliminar los aromas de pescado en productos alimenticios mediante proteínas
US20080145506A1 (en) * 2006-12-18 2008-06-19 Bodybio, Inc. Food compositions and products containing balanced ratio of essential fatty acids
US20090258833A1 (en) * 2008-04-10 2009-10-15 Edward Walker Fortified liquid protein compositions and methods of making same
EP2398472A2 (de) * 2009-01-14 2011-12-28 Katholieke Universiteit Leuven, K.U. Leuven R&D Verfahren und zubereitungen für den schutz von kritisch kranken patienten mit einem polyamin (z.b. spermin, spermidin)
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
SG11201504690YA (en) 2012-12-18 2015-07-30 Abbott Lab Low viscosity, high caloric density oral nutritional composition and related methods
CN105188416A (zh) * 2013-03-12 2015-12-23 雅培制药有限公司 包含多功能粘度调节剂的组合物
US10568337B1 (en) * 2014-04-30 2020-02-25 Jayson Calton Method and composition for providing liquid coconut oil
WO2017134256A1 (en) * 2016-02-03 2017-08-10 Fresenius Kabi Deutschland Gmbh High caloric, high protein nutritional formula
ES2737950T3 (es) * 2016-09-23 2020-01-17 Fresenius Kabi Deutschland Gmbh Composiciones nutricionales líquidas ricas en calorías tratadas por UHT
EP3711493A1 (de) * 2016-11-16 2020-09-23 Fresenius Kabi Deutschland GmbH Ernährungszusammensetzung zur verwendung in der therapie von patienten mit sarkopenie und/oder gebrechlichkeit oder von patienten kurz vor der sarkopenie und/oder gebrechlichkeit
US11147835B1 (en) 2020-08-20 2021-10-19 Frank Kelly Reilly, III Nutritional supplement

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042688A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of providing high-protein nutrition by the oral administration of a predigested protein composition
US4438144A (en) * 1980-07-31 1984-03-20 Blackburn George L Amino acid preparation and therapy for treatment of stress and injury
FR2556593B1 (fr) * 1983-12-20 1987-01-02 Synthelabo Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
JPS61192245A (ja) * 1985-02-21 1986-08-26 Snow Brand Milk Prod Co Ltd アルギニン配合粉乳
US4850704A (en) * 1986-08-28 1989-07-25 Ladish Co. Two stage blender
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
EP0312612B1 (de) * 1987-05-01 1993-03-24 Otsuka Pharmaceutical Co., Ltd. Nährmittelemulsion
EP0362724A3 (de) * 1988-10-07 1991-10-09 BASF Aktiengesellschaft Thermoplastische Formmasse
EP0507872B1 (de) * 1989-12-29 2000-04-26 B. Braun Medical Inc. Verwendung von arginin als immunstimulator
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products

Also Published As

Publication number Publication date
AU3614393A (en) 1993-09-13
JP2644086B2 (ja) 1997-08-25
CA2128078A1 (en) 1993-09-02
GR3030642T3 (en) 1999-10-29
NZ249392A (en) 1996-01-26
US5221668A (en) 1993-06-22
JPH07500348A (ja) 1995-01-12
EP0630181A4 (de) 1995-07-26
DE69325091T2 (de) 1999-12-23
EP0630181A1 (de) 1994-12-28
EP0630181B1 (de) 1999-05-26
WO1993016595A1 (en) 1993-09-02
HK1011597A1 (en) 1999-07-16
MX9300999A (es) 1993-09-01
DK0630181T3 (da) 1999-11-15
CA2128078C (en) 2002-03-19

Similar Documents

Publication Publication Date Title
DE69325091T2 (de) Ernährungsprodukt für verletzte und chirurgische patienten
DE69313483D1 (de) Verpackung für endoskopische Nahtschleife und Kanüle
DE69416332T2 (de) Einführungsstilett für medizinsche kanüle und kanüle
GB2277826B (en) Surgical and/or clinical apparatus
GB9415125D0 (en) Surgical product and its use
SG44341A1 (en) Sick or wounded patient bed having separable frame and moving/lifting apparatus for the separable frame
IL103290A0 (en) Ophthalmologic examination and/or treatment apparatus
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69319704T2 (de) Sterilisierte Verpackung für chirurgische Geräte
DE69201632T2 (de) Liegetische und Überwachungsgeräte für Patienten.
DE69332952D1 (de) Diagnostische und therapeutische Einheiten enthaltende biokompatible Polymere
NO933000D0 (no) Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer
DE9218322U1 (de) Einrichtung für die minimal invasive Therapie und Mikrotherapie
ATA113492A (de) Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven
DE59309732D1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
AU2143892A (en) Use of formoterol for treatment of tissue injury
GB8921737D0 (en) Device for surgical treatment of ametropia
GB8921738D0 (en) Device for surgical treatment of ametropia
DE29508984U1 (de) Bett für Pflege- und/oder Krankenhauszwecke
PT7956U (pt) Colchao ortopedico e medicinal
BR9502534A (pt) Tabela de consulta para diagnóstico e tratamento erapêutico
HU211363B (en) Medical bandaging product for first aid
ATE183090T1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
DE9418910U1 (de) Kranken- und/oder Pflegebett
BR6900691U (pt) Colchao ortopedico e medicinal

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 630181

Country of ref document: EP